Skip to main content icon/video/no-internet

ALTHOUGH AMERICAN SCIENTISTS have made major contributions in stem cell research, progress has been limited by political decisions which have their basis in religious and ethical concerns rather than scientific considerations. Stem cell research is not prohibited in the United States, but restrictions on federal funding (which is the major source of funding for scientific research in this country) mean that less research is conducted in this area than would be expected if such restrictions were removed. Because of the political and religious basis of the restrictions, they could be changed at any time. In addition, recent scientific advances may make the major issues of the stem cell research controversy moot: for example in November 2007 by Shinya Yamanaka and James Thomson, working independently, both reported success in reprogramming human skin cells to have the characteristics of human embryonic stem cells (hESCs). However, as of mid-2008 stem cell research in the United States was funded through a patchwork of state, private, and federal sources, with the latter limited to stem cell lines in existence as of August 9, 2001.

Federal Regulations and Funding

Stem cell research is conducted with both embryonic and adult stem cells, and with both human and animal cells. Research with adult stem cells and non—human stem cells is relatively non—controversial: most of the disputes center around research with hESCs, which as the name suggests are derived from human embryos. Because creating a stem cell line from an embryo requires destruction of the embryo, some people object to the process on religious or other ethical grounds, arguing that destroying an embryo is the moral equivalent of killing a human being. This belief makes stem cell research a controversial topic in the United States (in a way which it is not in many Western European countries, for instance) and is the basis for the current prohibition on federal funding to create new stem cell lines or for research using newly created lines. Major organizations which oppose hESC research include the Catholic Church, the organization Do No Harm—The Coalition of Americans for Research Ethics, and the National Right to Life Committee.

There is no federal law prohibiting the creation of new stem cell lines from embryos, and neither is there any federal law prohibiting the destruction of embryos. In fact, fertility clinics regularly create many more embryos than they expect to use (the Rand Institute estimated in 2001 that over 400,000 such embryos were stored in clinic freezers at that time), and these embryos are routinely destroyed when no longer needed. The reason stem cell research in the United States is limited, relative to other industrialized countries, is because the expense of scientific research has traditionally been borne by the federal government, and there is no other source of funding adequate to replace federal funding.

Opposition to stem cell research in the United States is often traced to opposition to abortion, and there is a historical connection between the two issues. After the Roe v. Wade decision of the U.S. Supreme Court in 1973 overturned most state laws banning abortion, the Department of Health, Education and Welfare (now the Department of Health and Human Services) of the federal government imposed a moratorium on research with living embryos. The following year, Congress imposed a moratorium on federal funding for research using embryonic or fetal tissue. Both restrictions were motivated in part by the fear that the availability of legal abortion would lead to exploitation of aborted fetuses and embryos, or that the medical or economic value of fetal and embryonic tissue might induce some women to undergo abortion. As is the case with stem cell funding today, Congress did not ban research with fetal and embryonic tissue, but only the provision of federal funds for it. Studies involving embryonic or fetal tissue, which includes much infertility treatment and research, are most commonly funded by private companies.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading